Welcome to the e-CCO Library!

P626: Development of a model of 3D imaging for the pre-operative planning of TaTME
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Sahnan1*, G. Pellino2, S.O. Adegbola1, P.J. Tozer1, P. Chandrasinghe3, D. Misovikc1, R. Hompes4, A.L. Hart5, J. Warusavitarne1, P.F. Lung6

Created: Thursday, 21 February 2019, 9:14 AM
P626: Higher discontinuation rates of anti-TNF therapy in elderly IBD patients compared with a younger age group: results from a prospective registry
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Smits*1, M. de Jong1, N. den Broeder1, M. Russel2, T. Römkens3, R. West4, J. Jansen5, F. Hoentjen1

Created: Friday, 22 February 2019, 9:41 AM
P626: Safety of recombinant zoster vaccine in patients with Inflammatory Bowel Disease: a single centre experience
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Todeschini, A.(1)*;Geccherle, A.(1);Signoretto, P.(1);Variola, A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P626: SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: García Mateo, S.(1,2);Martínez-Domínguez, S.J.(1,2);Aso Gonzalvo, M.C.(1);Gargallo-Puyuelo, C.J.(1,2,3);Gallego Llera, B.(1,2);Arroyo Villarino, M.T.(1,2,3);Laredo de la Torre, V.(1,2);Nocito Colon, M.M.L.(4);Lario Quilez, L.(1);Refaie, E.(5);Latre Santos, M.(3);Gomollón García, F.(1,2,3,6);
Created: Wednesday, 2 June 2021, 4:12 PM
P626: Ustekinumab for the treatment of perianal fistulas in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Battat R.*1,2, Bessissow T.1, Strohl M.1, Kopylov U.3, Bitton A.1, Cohen A.2, Seidman E.1, Afif W.1

Created: Wednesday, 20 February 2019, 10:36 AM
P627 Acute severe ulcerative colitis in pregnancy: A retrospective cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Ollech1, I. Avni-Biron2, S. Dalal1, L. Glick1, S. Schafer1, J. Pekow1, R. Cohen1, D. Rubin1, A. Sakuraba1

Created: Thursday, 30 January 2020, 10:12 AM
P627: Change in urgency among ulcerative colitis patients: Analyses from the SPARC IBD
Year: 2021
Source: ECCO'21 Virtual
Authors: Lewis, J.(1);Shan, M.(2);Xhou, X.(2);Naegeli, A.(2);Hunter, T.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P627: HLA DQA1*05 was not associated to primary non-response or loss of response to first anti-TNF in real world Inflammatory Bowel Disease patients.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pascual Oliver, A.(1)*;Cuarán, C.(1);Casas-Deza, D.(1,2);García-López, S.(1,2);Corsino-Roche, P.(1,2);Sierra Moros, E.(1);Julián-Gomara, A.B.(1);Vicente-Lidón, R.(1);
Created: Friday, 14 July 2023, 11:05 AM
P627: Stopping anti-tumour necrosis factor (TNF) therapy in patients with perianal Crohn’s disease: Results from a population-based study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. Y. Mak*1, W. Tang1, F. K. L. Chan1, W. K. Leung2, M. K. K. Li3, F. H. Lo4, C. K. M. Ng5, A. S. F. Sze6, C. M. Leung7, S. W. C. Tsang8, E. H. S. Shan9, K. H. Chan10, B. C. Y. Lam11, A. J. Hui12, W. H. Chow13, J. J. Y. Sung1, S. C. Ng1

Created: Friday, 22 February 2019, 9:41 AM
P627: Surrogate markers of mucosal healing in Crohn's disease patients in clinical remission under biological/immunomodulator treatment
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Siakavellas S., Kostas A., Kosmidis C., Gizis M., Papatheodoridis G., Bamias G.

Created: Wednesday, 20 February 2019, 10:36 AM
P627: Variables associated with evolution to moderate to severe Crohn's disease at two reference centers in Salvador, Bahia, Brazil
Year: 2022
Source: ECCO'22
Authors: Da Silva Beda Sacramento, C.(1);Pamponet Motta, M.(2);Oliveira Alves, C.(2);Araujo Mota, J.(3);Goes de Codes, L.M.(1);Freitas Ferreira, R.(4);de Almeida Silva, P.(4);do Prado Palmiro, L.(4);Miranda Barbosa, R.(4);Nery Andrade, M.(5);Damasceno Andrade, V.(5);Brandão Vasconcelos, V.(5);Wasconcellos Thiara, B.(6);Martins Netto, E.(7);Oliveira Santana, G.(7);
Created: Friday, 11 February 2022, 3:56 PM
P628 Histological remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Narula1, A.A. Alshahrani1, M. Fadida1, M. Al-Saedi1, J.K. Marshall1, D.T. Rubin2, B. Christensen3

Created: Thursday, 30 January 2020, 10:12 AM
P628: Anti-TNF therapy in refractory pouchitis and Crohn's disease-like complications of the pouch after ileal pouch-anal anastomosis following colectomy for ulcerative colitis: a systematic review and meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Huguet M.1, Pereira B.2, Goutte M.1,3, Goutorbe F.1,4, Allimant C.1, Reymond M.1, Bommelaer G.1,3, Buisson A.*1,3

Created: Wednesday, 20 February 2019, 10:36 AM
P628: Long-term outcomes with transmural healing vs. mucosal healing in Crohn’s disease: time for new treatment goals ?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. Castiglione1, N. Imperatore*1, A. Testa1, G. D. De Palma2, O. M. Nardone1, L. Pellegrini1, N. Caporaso1, A. Rispo1

Created: Friday, 22 February 2019, 9:41 AM
P628: Processed and ultra-processed food and risk of Inflammatory Bowel Disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD)
Year: 2022
Source: ECCO'22
Authors: Dong, C.(1,2);Casagrande, C.(3);Chan, S.(4,5);Huybrechts, I.(3);Nicolas, G.(3);Boutron-Ruault, M.C.(2);Carbonnel, F.(1,2);
Created: Friday, 11 February 2022, 3:56 PM
P628: Risk Factors Associated with Extraintestinal Manifestations in Patients with Inflammatory Bowel Diseases
Year: 2021
Source: ECCO'21 Virtual
Authors: Liava, C.(1);Sinakos, E.(1);Dimitroulas, T.(1);Navrozidou, C.(2);Akriviadis, E.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P628: Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ledder, O.(1)*;Dubinsky, M.(2);Dolinger, M.(2);Fatima, A.(3);Suskind, D.(4);Scarlett, J.(4);Röeser, D.(5);Shouval, D.(6);Meyer, G.(7);Molle Rios, Z.(7);Pujol, G.(8);Lozano, A.(8);Kolho, K.L.(9);Rohani, P.(10);Hussey, S.(11);de Mejj, T.(12);Ayers, T.(13);Navas López, V.M.(14);Turner, D.(1);Tzivinikos, C.(15);
Created: Friday, 14 July 2023, 11:05 AM
P628: Transfer of care of adolescent IBD patients without longitudinal transition: Lesson from 10-year experiences
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Szántó1*, K. Farkas1, M. Rutka1, A. Bálint1, R. Bor1, Á. Milassin1, A. Fábián1, Z. Szepes1, F. Nagy1, N. Vass2, D. Szűcs2, T. Molnár1

Created: Thursday, 21 February 2019, 9:14 AM
P629 Long-term effectiveness and safety of ustekinumab (UST) in patients with active Crohn’s disease (CD) in real life: Interim analysis of the SUSTAIN study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Chaparro1, S. Sulleiro2, I. Bastón-Rey3, C. Rodríguez4, I. García-Tercero5, P. Ramírez6, S. García-López7, M. Rojas-Feria8, A. Gutiérrez9, J.M. Huguet Malavés10, M.F. García-Sepulcre11, B. Sicilia12, F. Bermejo13, F. Rodríguez-Moranta14, F. Argüelles15, I. Marín16, E. Leo17, M. Arroyo18, M.J. García19, J.M. Vázquez20, D. Ginard21, J. Martínez Cadilla22, C. Rubín de Célix1, A. García-Herola23, A. Hernández-Camba24, M.D. Martín-Arranz25, S. Riestra26, P. Varela27, B. Velayos28, D. Busquets29, C. Dueñas30, E. Fernández-Salgado31, P. Martínez-Montiel32, M.T. Diz-Lois33, Y. González-Lama34, A. Muñagorri35, M. Navarro-Llavat36, C. Guisado2, M. Barreiro-de Acosta3, J.P. Gisbert1, on behalf of SUSTAIN Study Group

Created: Thursday, 30 January 2020, 10:12 AM